
The Digestive Diseases Society recognizes the combination of lacto and bifidobacteria in BIOTIC GASTRO IBS™, confirming it with the logo of the Digestive Diseases Society.
The intestines are the largest organ of the immune system in the human body, and they react most sensitively to external stress factors.
The use of antibiotics, travel, poor diet, stress are just some of the factors that can negatively affect the human gastrointestinal tract, risking disrupting the balance of bacteria, thereby changing the body's natural defenses.
BIOTIC GASTRO IBS™ - a dietary supplement, probiotics. It combines five specific clinically studied bacterial strains Lactobacillus acidophilus NCFM®, Lacticaseibacillus paracasei Lpc-37®, Bifidobacterium lactis Bi-07®, Bifidobacterium lactis BI-04® and Bifidobacterium lactis HN019™️.
These patented bacterial strains are included in the guidelines of the World Gastroenterology Organization (WGO).
One capsule contains 30 billion bacteria. Their effects have been studied in both preclinical and clinical studies, following Good Clinical Practice (GCP) guidelines.
¹ Harris, Lucinda A., Brooks D. MD, Moftah, Karim, Franklin, Howard et. al. Journal of Clinical Gastroenterology 56(5):p 444-451, May/June 2022.
The Digestive Diseases Society recognizes the combination of lacto and bifidobacteria in BIOTIC GASTRO IBS™, confirming it with the logo of the Digestive Diseases Society.
The intestines are the largest organ of the immune system in the human body, and they react most sensitively to external stress factors.
The use of antibiotics, travel, poor diet, stress are just some of the factors that can negatively affect the human gastrointestinal tract, risking disrupting the balance of bacteria, thereby changing the body's natural defenses.
BIOTIC GASTRO IBS™ - a dietary supplement, probiotics. It combines five specific clinically studied bacterial strains Lactobacillus acidophilus NCFM®, Lacticaseibacillus paracasei Lpc-37®, Bifidobacterium lactis Bi-07®, Bifidobacterium lactis BI-04® and Bifidobacterium lactis HN019™️.
These patented bacterial strains are included in the guidelines of the World Gastroenterology Organization (WGO).
One capsule contains 30 billion bacteria. Their effects have been studied in both preclinical and clinical studies, following Good Clinical Practice (GCP) guidelines.
¹ Harris, Lucinda A., Brooks D. MD, Moftah, Karim, Franklin, Howard et. al. Journal of Clinical Gastroenterology 56(5):p 444-451, May/June 2022.
/75/88/52e12055907058e273b8ae1e3a2c.png)
/e5/f0/1a1a50b0625be2412a8678ac6969.png)
/73/e5/8675d7701b693494de22d1465fee.png)
/eb/7c/308120c3f73d0998cfe1eabe5301.png)